Welltower director granted 1,056 stock units

DeSalvo Karen B reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 02/27/2026 - 04:47 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

DeSalvo Karen B reported acquisition or exercise transactions in this Form 4 filing.

Welltower Inc. director Karen B. DeSalvo reported an equity award of 1,056 deferred stock units of common stock, granted without cash consideration under the Amended and Restated Welltower Inc. 2022 Long-Term Incentive Plan. These units vest and will be settled in common stock on February 26, 2027. Following this grant, she directly owns 12,369.59 shares of Welltower common stock.

Insider Trade Summary

Grant/Award: 1,056 shares

Grant/Award 1 txn

Insider DeSalvo Karen B

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,056	$0.00	$0.00

Holdings After Transaction: Common Stock — 12,369.59 shares (Direct)

Footnotes (1)

1. F1. These shares represent deferred stock units that were granted without cash consideration on February 26, 2026 under the Amended and Restated Welltower Inc. 2022 Long-Term Incentive Plan. Each deferred stock unit will be settled in common stock upon vesting on February 26, 2027.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did WELL director Karen B. DeSalvo report?

Karen B. DeSalvo reported receiving an award of 1,056 deferred stock units of Welltower common stock. The units were granted without cash consideration under the Amended and Restated Welltower Inc. 2022 Long-Term Incentive Plan as of February 26, 2026.

How many Welltower (WELL) shares does Karen B. DeSalvo own after this Form 4?

After the reported award, Karen B. DeSalvo directly owns 12,369.59 shares of Welltower common stock. This total reflects her holdings following the grant of 1,056 deferred stock units reported in the Form 4 filing.

What are the terms of the 1,056 deferred stock units granted by WELL?

The 1,056 deferred stock units were granted without cash consideration under Welltower’s 2022 Long-Term Incentive Plan. Each deferred stock unit will be settled in Welltower common stock upon vesting, which is scheduled for February 26, 2027, according to the filing footnote.

When will the WELL deferred stock units reported by Karen B. DeSalvo vest?

The deferred stock units granted to Karen B. DeSalvo are scheduled to vest on February 26, 2027. Upon vesting, each deferred stock unit will be settled in Welltower common stock, as described in the Form 4 footnote disclosure.

Under which plan were the WELL deferred stock units granted to Karen B. DeSalvo?

The deferred stock units were granted under the Amended and Restated Welltower Inc. 2022 Long-Term Incentive Plan. The Form 4 notes that the award consisted of deferred stock units granted without cash consideration to the reporting director.

Did Karen B. DeSalvo pay a purchase price for the 1,056 WELL deferred stock units?

No, the 1,056 deferred stock units were granted without cash consideration. The transaction code indicates a grant or award acquisition, and the footnote confirms they were issued as an equity award under Welltower’s 2022 Long-Term Incentive Plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DeSalvo Karen B

(Last) (First) (Middle)

4500 DORR STREET

(Street)

TOLEDO OH 43615

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
WELLTOWER INC. [ WELL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/26/2026(1)		A		1,056(1)	A	$0	12,369.59	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares represent deferred stock units that were granted without cash consideration on February 26, 2026 under the Amended and Restated Welltower Inc. 2022 Long-Term Incentive Plan. Each deferred stock unit will be settled in common stock upon vesting on February 26, 2027.

	Matthew McQueen Attorney-in-Fact For: Karen DeSalvo	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.